Jeff Nagge
Clinical Associate Professor
Email: jnagge@uwaterloo.ca
Location: PHR 5001
Phone: 519-888-4567 x21312
Biography
Dr. Nagge’s clinical and research interests include cardiovascular risk reduction, anticoagulation therapy, translating evidence into practice, and shared decision making.
Dr. Nagge’s primary research interests are driven by questions routinely encountered in his clinical practice that lack solutions supported by a solid evidence base. Examples of this include the development of strategies to optimize the management of anticoagulation therapy, and evaluating the effectiveness and safety of various pharmacological alternatives for cardiovascular risk reduction.
Dr. Nagge also practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener.
His clinical interests include anticoagulation, cardiovascular therapeutics, evidence-informed practice, and shared decision-making. He practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener, where he developed several innovative clinical services including a point-of-care anticoagulation clinic, arterial and venous thrombosis clinics, and a cardiovascular risk reduction clinic. He has supervised hundreds of undergraduate and post-graduate Pharmacy and Medical learners in these clinics, and trained more than 200 practicing pharmacists, nurses and nurse practitioners in MOAT, a blended-learning, continuing education course that teaches clinicians how to manage oral anticoagulant therapy in primary care settings.
Dr. Nagge’s primary research interests are driven by questions routinely encountered in his clinical practice that lack solutions supported by a solid evidence base. Examples of this include the development of strategies to optimize the management of anticoagulation therapy, and evaluating the effectiveness and safety of various pharmacological alternatives for cardiovascular risk reduction.
Dr. Nagge also practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener.
His clinical interests include anticoagulation, cardiovascular therapeutics, evidence-informed practice, and shared decision-making. He practices as a clinical consultant at the Centre for Family Medicine Academic Family Health team in Kitchener, where he developed several innovative clinical services including a point-of-care anticoagulation clinic, arterial and venous thrombosis clinics, and a cardiovascular risk reduction clinic. He has supervised hundreds of undergraduate and post-graduate Pharmacy and Medical learners in these clinics, and trained more than 200 practicing pharmacists, nurses and nurse practitioners in MOAT, a blended-learning, continuing education course that teaches clinicians how to manage oral anticoagulant therapy in primary care settings.
Research Interests
- Cardiovascular risk reduction
- Anticoagulation therapy
- Translating evidence into practice
- Shared decision-making
- Clinical Pharmacy and Pharmacy Practice
Education
- 2004 PharmD, University of Toronto, Canada
- 2000 BScPhm, University of Toronto, Canada
- 1995 BSc (Honours Science, Minor in Chemistry), University of Waterloo, Canada
Awards
- 2014 Interprofessional Preceptor of the Year Award. Michael G. DeGroote School of Medicine, McMaster University, Kitchener-Waterloo and area Family Medicine Residency program
- 2012 Interprofessional Preceptor of the Year Award. Michael G. DeGroote School of Medicine, McMaster University, Kitchener-Waterloo and area Family Medicine Residency program
- 2011 Excellence in Teaching – Academic (undergraduate). Michael G. DeGroote School of Medicine, McMaster University, Waterloo Regional Campus
- 2010 Canadian Society of Hospital Pharmacists Western Branches Seminar Best Research Poster Award
- 2007 Doctor of Pharmacy Preceptor of the Year. University of Toronto, Faculty of Pharmacy
Service
- 2015- Best practices committee, Centre for Family Medicine Family Health Team, member
- 2006-2009 E-health committee, Waterloo-Wellington Local Health Integration Network
- 2001-2010 Canadian Society of Hospital Pharmacists Educational Services Committee
- 2010- British Medical Journal, peer-reviewer
- 2010- Annals of Internal Medicine, peer-reviewer
- 2005-Canadian Journal of Hospital Pharmacy, peer-reviewer
Teaching*
- OPTOM 231 - Introductory Clinical Pharmacology
- Taught in 2019, 2020, 2021
- PHARM 222 - Integrated Patient Focused Care 3
- Taught in 2020, 2021, 2022, 2023
- PHARM 223 - Integrated Patient Focused Care 4
- Taught in 2019
- PHARM 422 - Integrated Patient Focused Care 9
- Taught in 2019, 2020, 2021, 2022, 2024
- PHARM 467 - Management of Oral Anticoagulation Therapy
- Taught in 2019, 2020, 2021, 2022, 2024
- PHARM 651 - Advanced Principles of Medication Management 1
- Taught in 2021
* Only courses taught in the past 5 years are displayed.
Selected/Recent Publications
- Sridhar V, Ho-Yan Leung P, Seymour N, Nagge J. Evaluation of a 4mg warfarin initiation protocol for atrial fibrillation in the outpatient Setting. Canadian Family Physician. Canadian Family Physician 2014;60:e535-40.
- Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C, Mamdani MM, Juurlink DN. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: A population-based cohort study. Annals of Internal Medicine 2013;158(6):447-455.
- Nagge J, Juurlink DN. A population-based comparison of the cardiovascular protective effects of hydrochlorothiazide and chlorthalidone. Circulation. 2007;116:459.
- Nagge J, Knowles S, Shear N, Juurlink D. Pseudoephedrine-induced toxic epidermal necrolysis. Archives of Dermatology 2005;141:907-8.
- Nagge J, Jackevicius C, Dzavik V, Ross J, Seidelin P. Acute profound thrombocytopenia associated with eptifibatide therapy. Pharmacotherapy 2003; 374-9.
- Nagge J, Crowther M, Hirsh J. Is renal impairment a contraindication to the use of low molecular weight heparin? Archives of Internal Medicine 2002;162:2605-9.